Executive Summary
The objective was to compare effects of GnRH antagonist and standard long protocol agonist on number, and the quality of Metaphase II oocytes, and on reducing risk of hyperstimulation, in patients who are affected by Polycystic ovarian syndrome. Polycystic ovarian syndrome is a common endocrinopathy of the women who are in reproductive age, which is a first cause of the anovulation. GnRH agonists are used in the IVF to avoid premature LH surge before the retrieval of oocyte. Research findings from this study can be significant to various Centers for Reproductive Medicine, and also to all the institutions that practice ART. ...
